AMSTERDAM

25-28 SEP 2024

Pre-exposure prophylaxis (PrEP) to prevent HIV infection

Prep hiv

Presentation ID D2T12.2D

Session type: Updates
Room: G102-G103
Date: Thursday, 26 Sep, 11:15 – 11:35 CEST

Part of Session: STI Prevention

PD Dr. med. Laurence Toutous-Trellu

(Geneva, Switzerland)

The fight against new HIV infections is active and many countries target the objective of ending the HIV/AIDS epidemic as a public health threat by 2030, in Europe but also in other continents including Africa. Today, the control of new cases of HIV infection requires multiple different aspects: use of condoms, regular testing and treatment when infection is diagnosed, well controlled viral infection under antiretroviral drugs in infected people, and pharmacological prevention in people non-infected people, as well as detection and treatment of the other sexually transmitted infections.

The use of antiretroviral in non-infected people before a high-risk behavior has been expanded for years.

The objectives of this lecture are:

  • To learn the target populations for such prophylaxis and identify the potential risks for specific individuals.
  • To know the commercialized drugs and their development.
  • To adapt the knowledge to local practice, taking into consideration a multidisciplinary approach and the public health context.

Explore the extensive Congress programme featuring the latest scientific advances and research in dermatology & venereology.

Share this article:
Facebook
Twitter
LinkedIn